- Page 1 and 2: Genetic susceptibility to adverse d
- Page 3: The work presented in this thesis w
- Page 10: 1 General Introduction
- Page 13 and 14: Chapter 1 genome. Every SNP represe
- Page 15 and 16: Chapter 1 References 1. 2. 3. 4. 5.
- Page 18: 2 Quantifying the risk of adverse d
- Page 21 and 22: Chapter 2 Introduction The cardiac
- Page 23 and 24: Chapter 2 Table 1 Characteristics o
- Page 25 and 26: Chapter 2 digoxin treatment appears
- Page 27 and 28: Chapter 2 References 1. 2. 3. 4. 5.
- Page 30: 3 Common variants in the ABCB1 gene
- Page 33 and 34: Chapter 3.1 Introduction The ATP-Bi
- Page 35 and 36: Chapter 3.1 Co-variables. Covariate
- Page 37 and 38: Chapter 3.1 Table 3 Frequencies of
- Page 39 and 40: Chapter 3.1 Table 5 Risk of serum d
- Page 41 and 42: Chapter 3.1 Table 6 Other studies o
- Page 43 and 44: Chapter 3.1 References 1. 2. 3. 4.
- Page 46 and 47: 3.2 Common ABCB1 variants increase
- Page 48 and 49: Common ABCB1 variants increase QTc
- Page 50 and 51: Common ABCB1 variants increase QTc
- Page 52 and 53: Common ABCB1 variants increase QTc
- Page 54 and 55:
Common ABCB1 variants increase QTc
- Page 56 and 57:
Common ABCB1 variants increase QTc
- Page 58:
Common ABCB1 variants increase QTc
- Page 61 and 62:
Chapter 3.3 Introduction The quinol
- Page 63 and 64:
Chapter 3.3 In addition to the diar
- Page 65 and 66:
Chapter 3.3 Table 1 General charact
- Page 67 and 68:
Chapter 3.3 confounding by contrain
- Page 69 and 70:
Chapter 3.3 adverse effects of mefl
- Page 71 and 72:
Chapter 3.3 References 1. 2. 3. 4.
- Page 74:
4 Common variants in the NOS1AP gen
- Page 77 and 78:
Chapter 4.1 Introduction Sudden car
- Page 79 and 80:
Chapter 4.1 Assessment of QTc inter
- Page 81 and 82:
Chapter 4.1 Table 1 Baseline charac
- Page 83 and 84:
Chapter 4.1 Table 3 Number of indiv
- Page 85 and 86:
Chapter 4.1 ditional GG haplotype c
- Page 87 and 88:
Chapter 4.1 References 1. 2. 3. 4.
- Page 90 and 91:
4.2 Common NOS1AP variants potentia
- Page 92 and 93:
Common NOS1AP variants potentiate d
- Page 94 and 95:
Common NOS1AP variants potentiate d
- Page 96 and 97:
Common NOS1AP variants potentiate d
- Page 98 and 99:
Common NOS1AP variants potentiate d
- Page 100 and 101:
Common NOS1AP variants potentiate d
- Page 102:
Common NOS1AP variants potentiate d
- Page 105 and 106:
Chapter 4.3 Introduction In the pas
- Page 107 and 108:
Chapter 4.3 Figure 1 Flowdiagram of
- Page 109 and 110:
Chapter 4.3 Table 1 Characteristics
- Page 111 and 112:
Chapter 4.3 Table 2 Cardiovascular
- Page 113 and 114:
Chapter 4.3 Table 3 Drugs, NOS1AP a
- Page 115 and 116:
Chapter 4.3 found indication that t
- Page 117 and 118:
Chapter 4.3 References 1. 2. 3. 4.
- Page 120 and 121:
4.4 Common variation in the NOS1AP
- Page 122 and 123:
Common variants in the NOS1AP gene
- Page 124 and 125:
Common variants in the NOS1AP gene
- Page 126 and 127:
Common variants in the NOS1AP gene
- Page 128 and 129:
Common variants in the NOS1AP gene
- Page 130 and 131:
Common variants in the NOS1AP gene
- Page 132:
Common variants in the NOS1AP gene
- Page 136 and 137:
5 Effect of ABCB1 and NOS1AP genoty
- Page 138 and 139:
Effect of ABCB1 and NOS1AP genotype
- Page 140 and 141:
Effect of ABCB1 and NOS1AP genotype
- Page 142 and 143:
Effect of ABCB1 and NOS1AP genotype
- Page 144 and 145:
Effect of ABCB1 and NOS1AP genotype
- Page 146 and 147:
Effect of ABCB1 and NOS1AP genotype
- Page 148 and 149:
Effect of ABCB1 and NOS1AP genotype
- Page 150:
Effect of ABCB1 and NOS1AP genotype
- Page 154 and 155:
6 General discussion Despite all re
- Page 156 and 157:
General discussion ening properties
- Page 158 and 159:
General discussion or the excess [C
- Page 160 and 161:
General discussion continuously mon
- Page 162 and 163:
General discussion cardiovascular d
- Page 164 and 165:
General discussion for non-cardiova
- Page 166 and 167:
General discussion 25. 26. 27. 28.
- Page 168 and 169:
General discussion QTc interval in
- Page 170:
General discussion 169
- Page 174 and 175:
7.1 Summary Despite all research ef
- Page 176:
Summary reduced mortality in patien
- Page 179 and 180:
Chapter 7.2 steeds aanzienlijk is e
- Page 182 and 183:
8 Dankwoord Een proefschrift schrij
- Page 184:
Dankwoord Bijzondere dank aan alle
- Page 188 and 189:
10 Bibliography Manuscripts based o
- Page 190:
Bibliography Van der Hooft CS, Diel